DIREKT: Disarming the intravascular innate immune response to improve modalities for chronic kidney disease treatment [ 2014 - 2016 ]

Also known as: Control of innate immunity to treat chronic kidney disease

Research Grant

[Cite as]

Researchers: Prof Peter Cowan (Principal investigator) ,  Prof Karen Dwyer

Brief description Dialysis is the mainstay treatment for patients with end-stage kidney disease while they await transplantation. However, the dialysis process causes inflammation in patients, affecting their health and longevity. This project aims to develop new bioreagents that can be applied to dialysis devices to reduce inflammation and thus improve patient outcomes. These bioreagents will also be used to modify donor kidneys so that they are protected from inflammation associated with transplantation.

Funding Amount $AUD 362,830.49

Funding Scheme Targeted Calls

Notes Aust/EU Collaborative Research Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]